This, combined with the continued performance of the CF franchise and the potential of other pipeline drugs, paints a compelling picture for Vertex's future. The company's strategic collaborations ...

Daybue was launched in the United States in April 2023 and is the first and only drug to be approved by the ... Acadia is evaluating its pipeline candidate, ACP-101, in the phase III COMPASS ...

Mr. Seo outlined IND submission timelines of its novel drug pipeline with plans to develop 13 new drugs by 2028, including 9 ADCs and 4 multispecific antibodies. Jin-Seok Seo added, ''Just two ...

Celltrion unveils strategic roadmap for the first time outlining its innovative drug development strategy and its plan to submit 13 Investigational New Drug (IND) application by 2028 Company ...

Growing up with CF, I always felt like my life was a ticking time bomb. Growing up, I didn’t really think about my own mortality and my life span; that all changed when I turned 18. I vividly remember ...

primarily revolving around the promising commercial prospects of Cytokinetics’ drug pipeline. The company’s strategic focus is on aficamten, which is anticipated to gain approval and be ...

Regeneron co-Chair, President and CSO George Yancopoulos discusses the company's planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco. South Korean ...

The diabetes drug metformin has been shown to reduce risk of skin cancer People taking metformin had a lower risk of the two most common skin cancers However, Black patients were not protected ...

Strategically focused pipeline ... cystic fibrosis (CF) following aerosol delivery. Given A101-enabled product candidate 4D-710’s proof of delivery, safety data and initial clinical activity signals, ...